Replies to post #4902 on Arbutus Biopharma Corporation (ABUS)

[Echo20]

Nanopatent

From the PRS was there any success mentioned,?

Any info that pointed to failure's?

The new formula. Should have been enough. But no data?

500 doses? Maybe good results and under lock and key from the Welcome people. Tight or no money? They could be that tight. That was phase 2?

Offers come in around then. Lock and key?

Very tight under welcome.

Best of success to you and TKMR.

Echo20